RUPCR Europe announces the opening of its new lab facility on Manchester Science Park. The custom designed facility will be focussed on becoming ISO13485 and begin manufacturing qPCR kits from the TRUPCR range. The space will also be used for R&D which will be targeted on developing a pipeline of qPCR and NGS kits.
The extensive TRUPCR range is focussed on oncology, infectious disease and human genetics. The range offers robust, highly sensitive and precise CE marked kits which can be used on a number of Real-time PCR platforms.
The facility will initially support the growing European customer base and is in line with the expansion plans and vision of becoming a leading supplier of clinical molecular diagnostics in Europe.
Harminder Singh, CEO of TRUPCR Europe said ‘I am delighted to announce this significant milestone which will allow us to support our European customers and collaborate with local organisations on R&D projects’
